vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and Ostin Technology Group Co., Ltd. (OST). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($37.2M vs $20.8M, roughly 1.8× Ostin Technology Group Co., Ltd.). On growth, Ostin Technology Group Co., Ltd. posted the faster year-over-year revenue change (39.2% vs -57.1%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Ostin Technology Group Co., Ltd. is a provider of display and interactive technology solutions. It develops and manufactures touch panels, interactive whiteboards and custom display modules, serving consumer electronics, education and commercial segments across Asia Pacific, North America and European markets.

ORGO vs OST — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.8× larger
ORGO
$37.2M
$20.8M
OST
Growing faster (revenue YoY)
OST
OST
+96.3% gap
OST
39.2%
-57.1%
ORGO

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
ORGO
ORGO
OST
OST
Revenue
$37.2M
$20.8M
Net Profit
$-5.2M
Gross Margin
30.8%
9.1%
Operating Margin
-185.1%
-23.4%
Net Margin
-24.8%
Revenue YoY
-57.1%
39.2%
Net Profit YoY
-11.6%
EPS (diluted)
$-2.98

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
OST
OST
Q1 26
$37.2M
Q4 25
$225.6M
Q3 25
$150.9M
Q2 25
$101.0M
Q1 25
$86.7M
$20.8M
Q4 24
$126.7M
Q3 24
$115.2M
Q2 24
$130.2M
Net Profit
ORGO
ORGO
OST
OST
Q1 26
Q4 25
$43.7M
Q3 25
$21.6M
Q2 25
$-9.4M
Q1 25
$-18.8M
$-5.2M
Q4 24
$7.7M
Q3 24
$12.3M
Q2 24
$-17.0M
Gross Margin
ORGO
ORGO
OST
OST
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
9.1%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
ORGO
ORGO
OST
OST
Q1 26
-185.1%
Q4 25
28.1%
Q3 25
13.7%
Q2 25
-12.5%
Q1 25
-30.9%
-23.4%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
-10.7%
Net Margin
ORGO
ORGO
OST
OST
Q1 26
Q4 25
19.4%
Q3 25
14.3%
Q2 25
-9.3%
Q1 25
-21.7%
-24.8%
Q4 24
6.1%
Q3 24
10.7%
Q2 24
-13.1%
EPS (diluted)
ORGO
ORGO
OST
OST
Q1 26
Q4 25
$0.31
Q3 25
$0.11
Q2 25
$-0.10
Q1 25
$-0.17
$-2.98
Q4 24
$0.05
Q3 24
$0.09
Q2 24
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
OST
OST
Cash + ST InvestmentsLiquidity on hand
$91.4M
$1.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7M
Total Assets
$520.0M
$52.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
OST
OST
Q1 26
$91.4M
Q4 25
$93.7M
Q3 25
$63.7M
Q2 25
$73.1M
Q1 25
$110.0M
$1.7M
Q4 24
$135.6M
Q3 24
$94.3M
Q2 24
$89.9M
Total Debt
ORGO
ORGO
OST
OST
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Stockholders' Equity
ORGO
ORGO
OST
OST
Q1 26
Q4 25
$300.1M
Q3 25
$255.1M
Q2 25
$233.2M
Q1 25
$242.9M
$2.7M
Q4 24
$262.9M
Q3 24
$278.5M
Q2 24
$263.5M
Total Assets
ORGO
ORGO
OST
OST
Q1 26
$520.0M
Q4 25
$598.7M
Q3 25
$509.8M
Q2 25
$461.1M
Q1 25
$467.4M
$52.6M
Q4 24
$497.9M
Q3 24
$446.3M
Q2 24
$443.2M
Debt / Equity
ORGO
ORGO
OST
OST
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons